Home > Insider Trading > Filing (0001209191-18-052151)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1183765	Molecular Templates Inc.	MTEM	Pharmaceutical Preparations (2834)	943409596

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	2740 Sand Hill Road Second Floor Menlo Park CA 94025	No	No	Yes	No
1431159	Juliet Bakker Tammenoms	2740 Sand Hill Road Second Floor Menlo Park CA 94025	No	No	Yes	No
1674099	Longitude Venture Partners Iii, L.p.	2740 Sand Hill Road Second Floor Menlo Park CA 94025	No	No	Yes	No
1713663	Longitude Capital Partners Iii, Llc	2740 Sand Hill Road Second Floor Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-21	365,000	$5.50	3,261,535	No	4	P	Indirect	By Longitude Venture Partners III, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Longitude Venture Partners III, L.P.

Footnotes

These shares are held by Longitude Venture Partners III, L.P. ("Longitude Venture III"). This report is filed jointly by Longitude Capital Partners III, LLC ("Longitude Capital III"), Longitude Venture III, Patrick G. Enright ("Mr. Enright"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. Longitude Capital III is the general partner of Longitude Venture III and may be deemed to share voting and investment power over the shares held by Longitude Venture III. Mr. Enright and Ms. Bakker are the managing members of Longitude Capital III and may be deemed to share voting and investment power over the shares held by Longitude Venture III. Each of Longitude Capital III, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein.